Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Academic Article
Publication Date:
2020
Iris type:
1.1 Articolo in rivista
Keywords:
Adult; Aged; Aged, 80 and over; Antiviral Agents; B-Lymphocytes; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Lymphoproliferative Disorders; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Young Adult
List of contributors:
Frigeni, M.; Besson, C.; Visco, C.; Fontaine, H.; Goldaniga, M.; Visentini, M.; Pulsoni, A.; Torres, H. A.; Peveling-Oberhag, J.; Rossotti, R.; Zaja, F.; Rigacci, L.; Merli, M.; Dorival, C.; Alric, C.; Piazza, F.; Gentile, M.; Ferrari, A.; Pirisi, M.; Nassi, L.; Rattotti, S.; Frustaci, A.; Milella, M.; Cencini, E.; Defrancesco, I.; Ferretti, V. V.; Bruno, R.; Hermine, O.; Arcaini, L.
Published in: